Delivery Order SPE2DB22D2206-SPE2DB24FDZ40
Award Date 11/2/23
Potential Completion Date 11/27/23
Potential Value $13K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for $31,454.40 to supply 100 vials of Xeomin, a botulinum toxin used for medical treatments. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies delivered by December 13, 2023. No set-aside designation was applied to this award made against an existing DLA contract vehicle. As a leading...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to supply 200 unit vials of Xeomin, a botulinum toxin type A, in support of military treatment programs. Valued at $26,212.50, the delivery order was issued against an indefinite delivery contract vehicle and requires performance be completed by December 28, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No set aside designation was...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency Troop Support Medical to supply 100 vials of Xeomin, a botulinum toxin type A injection. The $13,106 order is for pharmaceutical products to support military treatment programs and will be fulfilled by December 2023, with performance taking place at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No set-aside designation was applied...
- Amerisourcebergen Drug Corporation, under its parent company Amerisourcebergen Corporation, has been awarded a delivery order contract valued at approximately $2,621 by the Defense Logistics Agency Troop Support Medical to provide 100 units of Xeomin, a botulinum toxin used for medical treatments. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of 13 days from August 11th through August 24th, 2023. Pricing is firm fixed. No subcontractors or set...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency Troop Support Medical to supply 100 vials of Xeomin, a botulinum toxin type A injection. Valued at $44,121.84, this order will support DLA Troop Support Medical's provision of pharmaceuticals and critical care supplies for military treatment facilities and programs. Performance will take place at Amerisourcebergen's Conshohocken, Pennsylvania...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $1,834.84 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide 100 units of Xeomin, a botulinum toxin type A injection used for medical conditions such as cervical dystonia and blepharospasm. Performance will take place in Conshohocken, Pennsylvania under contract number 4561778629. No subcontractors or set aside designations were indicated. This order is...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $44,036.16 to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. Performance will take place in Conshohocken, Pennsylvania over approximately three weeks concluding in early October. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will supply the botulinum toxin under a schedule contract vehicle to support DLA's medical supply needs. No set aside designation or...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,174.80 for 100-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic medical applications. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for completion by November 17, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $44,036.16 to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. Performance will take place in Conshohocken, Pennsylvania over a three week period concluding in mid-August. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the contract requirements without the use of major subcontractors. This delivery order was issued...
- The Defense Logistics Agency Troop Support Medical awarded a $6,290.88 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 vials of Xeomin. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between August 16 and September 7, 2023. As a major supplier of pharmaceuticals and medical supplies, Amerisourcebergen will provide the botulinum toxin under its corporate contract with DLA Troop Support to support treatment...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FDZ40Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $13,106 firm fixed price delivery order from the Defense Logistics Agency (DLA) to supply 100 vials of Xeomin, a botulinum toxin used for medical treatments. This order was placed against an existing indefinite delivery contract held by Amerisourcebergen Drug Corp with DLA Troop Support Medical to provide pharmaceuticals and medical supplies in support of military treatment programs. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 2023. No set-aside designation was applied to this award to supply the specified pharmaceutical product for DLA medical facilities.
Generated 2/1/24, 9:54 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 11/2/23 |